Status:
COMPLETED
The Effect of Exercise on Blood Glucose Levels in Patients With Type 1 Diabetes: A Comparison of 3 Long-acting Insulins
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Diabetes
Diabetes Mellitus, Type 1
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This trial is conducted in Europe. The aim of this research is to assess the impact of three basal (long-acting) insulin treatments on blood glucose levels in people with type 1 diabetes when performi...
Eligibility Criteria
Inclusion
- Type 1 Diabetes
- Current basal-bolus insulin therapy
- HbA1c \< 10%
- BMI \< 32 kg/m2
Exclusion
- Proliferative Retinopathy / Maculopathy
- Recurrent major hypoglycaemias
- Impaired hepatic or renal function
- Cardiac Problems
- Uncontrolled hypertension
Key Trial Info
Start Date :
April 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2006
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT00313742
Start Date
April 1 2006
End Date
November 1 2006
Last Update
November 2 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Neuss, Germany, 41460
2
Newcastle upon Tyne, United Kingdom, NE1 4LP